2017 in Review: San Antonio biotech companies score big wins

PUBLISHED ON December 29, 2017

San Antonio Business Journal (December 26, 2017) San Antonio-based bioAffinity Technologies Inc. hit the jackpot this summer. In July, I reported that the company had closed on its Series A funding round, raising more than $4 million — $1 million more than it had sought.

read more

bioAffinity Technologies adds talent in march to market

PUBLISHED ON December 11, 2017

San Antonio Business Journal (December 8, 2017) In an effort to shore up plans to commercialize its initial product, bioAffinity Technologies is adding more scientific and financial firepower to its arsenal. The San Antonio-based biotech is expanding its leadership team.

read more

bioAffinity Technologies Welcomes New Board Members

PUBLISHED ON November 30, 2017

SAN ANTONIO, TX (Nov. 29, 2017) bioAffinity Technologies, a privately held cancer diagnostics and therapeutics company, today announced the appointments of Stephen Squinto, Ph.D., and Gary Rubin, CPA, to its Board of Directors.

read more

bioAffinity Selected as One of Texas’s Healthcare Innovators

PUBLISHED ON November 5, 2017

San Antonio Business Journal (October 31, 2017) bioAffinity Technologies is proud to be chosen by the Texas Business Journals as one of the state's Healthcare Innovators. The recognition for our research that is leading to groundbreaking early cancer diagnostic tests by our dedicated team of scientists is truly appreciated.

read more

bioAffinity Technologies was selected as one of San Antonio’s Top 2020 Innovators. In this video, you will see Maria Zannes, President and Chief Executive Officer, speak about what drives motivation, innovation and success and kick off San Antonio’s premier annual event celebrating the City’s healthcare and bioscience industry.

 

www.thehealthcell.org/sitepage/state-of-the-industry/